Shaanxi will establish 11 drug storage bases in short supply

Source: Xinhuanet, November 29, 2017 The reporter learned from the health and Family Planning Commission of Shaanxi Province that Shaanxi Province has recently issued the implementation plan for the reform and improvement of the mechanism for ensuring the supply of drugs in short supply It is proposed that 11 bases for storing drugs in short supply will be established By the end of 2017, a mechanism for collecting, summarizing and analyzing information on drugs in short supply will be established In 2020, the comprehensive management of drug supply and the sharing of early warning information resources for shortage monitoring will be realized, and a mature and stable system will be established The system of real-time monitoring, early warning and graded response for the shortage of drugs According to the implementation plan, in order to improve the shortage drug reserve, Shaanxi will establish 11 shortage drug reserve bases in the whole province The reserve base is selected by large-scale distribution enterprises and undertakes the reserve work of drugs in short supply, emergency rescue and rare diseases in the whole province In addition, Shaanxi will expand the monitoring range and increase the monitoring points on the basis of the original 15 monitoring points All medical institutions directly under the provincial administration are included in the monitoring scope; each city divided into districts and cities selects one city public hospital and two county-level comprehensive hospitals to be included in the monitoring scope, and gradually forms a drug shortage information monitoring network at the provincial, municipal and county levels, as well as the three links of drug production, circulation and use that complement each other At the same time, Shaanxi will also strengthen the monitoring and early warning of the enterprises producing and distributing drugs in short supply, strengthen the supervision of the market of drugs and raw materials, investigate and deal with all kinds of illegal behaviors such as bid up prices and monopolies according to law, establish a blacklist system for dishonest operators, and formulate measures to prohibit the operators from engaging in the pharmaceutical industry in accordance with the law for those who repeatedly investigate the cases of monopoly of drugs in short supply and raw materials; Strictly implement the good faith record of drug purchase and the market clearing mechanism.